| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $111.8M | $82.1M | $79.9M |
| YoY Revenue Growth % | +36.2% | +2.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $17.9M | -$50.4M | -$36.8M |
| Operating Margin % | 16.0% | -61.4% | -46.1% |
| Net Income (GAAP) | -$26.0M | -$70.5M | -$65.8M |
| EBITDA (Normalized) | $18.1M | -$50.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$3.5M | -$41.8M | -$33.7M |
| Capital Expenditures (CapEx) | $221.0K | $354.0K | — |
| Free Cash Flow (FCF) | -$3.8M | -$42.2M | -$33.7M |
| FCF Margin % | -3.4% | -51.4% | -42.2% |
| Return on Invested Capital (ROIC %) | 2.7% | -5.3% | — |
| Cash & Short-Term Equivalents | $54.8M | $72.8M | — |
| Total Debt (Short + Long Term) | $462.9M | $677.0M | — |
| Total Stockholders' Equity | $118.8M | $143.7M | — |